Vadivarhe Speciality Chemicals share price & results
- Mar 2026
- Jun 2026
Nashik-based custom-synthesis manufacturer of speciality chemicals, APIs, drug intermediates and personal-care ingredients
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 28.7 | +22.6% YoY | Quarterly, as filed | Quarter to Mar 2026 | Revenue from operations as filed. |
| Operating margin | 10.7 | +29.8 pts YoY | Operating profit / revenue | Quarter to Mar 2026 | For the quarter; a change is in percentage points. |
| Net profit | 2.2 | Quarterly, as filed | Quarter to Mar 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. | |
| Return on equity | +36.2 pts | Trailing twelve months | TTM · period unavailable | Not in the analysed materials. No older figure is substituted. | |
| Free cash flow margin | 12.43 | +34.9 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | +26.2 pts | Trailing twelve months | TTM · period unavailable | Not in the analysed materials. No older figure is substituted. |
Price
Performance +0.6% 1Y
1Y: ₹24.35 on 16 Oct 2025 → ₹24.5. High ₹31.5 (6 Jul 2026), low ₹16.05 (29 Dec 2025).
- Previous close
- ₹24.5
- Market cap
- ₹31 Cr
- 52-week range
- ₹16.05 – ₹31.5
- One year
- +0.62%
- Return on equity (FY ending Mar 2026)
- 37.10%
Overview
- Symbol
- NSE:VSCL
- Sector
- Chemicals
- Industry
- Commodities
- Exchange
- NSE
- Currency
- INR
What Vadivarhe Speciality Chemicals Ltd does
Based on the company's own presentations, annual report and earnings calls.
Vadivarhe Speciality Chemicals Ltd (VSCL) manufactures organic and inorganic chemicals, bio-chemicals, bulk drugs, drug intermediates and Active Pharmaceutical Ingredients (APIs) through custom synthesis, from a WHO-GMP certified plant at Vadivarhe, near Nashik, Maharashtra. It supplies these speciality chemicals, APIs and intermediates to pharmaceutical formulation manufacturers and personal-care product makers. In FY25 it commenced commercial production of over 10 APIs, marking its entry into the pharmaceutical value chain alongside its existing speciality-chemicals business.
Segments
- Speciality Chemicals
- Active Pharmaceutical Ingredients (APIs)
- Intermediates & Personal Care Ingredients
- Manufacturing facilities
- 1 (Vadivarhe, Nashik, Maharashtra)
- APIs in commercial production
- 10+
- Certifications
- ISO 9001; WHO-GMP (manufacturing, marketing & supply of APIs and intermediates)
- Key clients
- 11 pharma/chem companies incl. GlaxoSmithKline Pharmaceuticals, USV, Mankind Pharma, Macleods, Hetero Labs, Micro Labs
- Product categories
- Speciality chemicals, APIs, drug intermediates, personal care ingredients
- Years in operation
- 16 (since incorporation in 2009)
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2021 to Mar 2026).
Financials
What the filings say
Net profit, year on year: +137% (quarter to mar 2026 against mar 2025).
| Line item | Sept 2022 | Mar 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 21 | 22 | 14 | 26 | 14 | 23 | 17 | 29 |
| Expenses | 20 | 21 | 15 | 21 | 16 | 28 | 20 | 26 |
| Operating profit | 2 | 2 | -1 | 5 | -2 | -4 | -2 | 3 |
| Operating margin | 7.3% | 7.8% | −6.5% | 19.0% | −13.4% | −19.1% | −14.4% | 10.7% |
| Other income | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 0 | 1 | -2 | 4 | -3 | -6 | -4 | 2 |
| Tax rate | 0.0% | 0.0% | 63.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net profit | 0 | 1 | -4 | 4 | -3 | -6 | -4 | 2 |
| EPS (₹ per share) | 0.13 | 0.77 | -2.93 | 2.98 | -2.58 | -4.66 | -3.01 | 1.73 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | -7 | -6 | -6 | -16 | -19 | -17 |
| Borrowings | 24 | 27 | 26 | 36 | 31 | 32 |
| Other liabilities | 12 | 13 | 9 | 9 | 14 | 11 |
| Total liabilities | 42 | 46 | 42 | 43 | 39 | 39 |
| Fixed assets | 24 | 23 | 22 | 22 | 22 | 21 |
| Capital work in progress | 1 | 1 | 2 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 16 | 22 | 18 | 20 | 17 | 17 |
| Total assets | 42 | 46 | 42 | 43 | 39 | 39 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | -0 | 1 | -0 | 2 | -7 | 6 |
| Cash from investing | 0 | -1 | -1 | -1 | -1 | -1 |
| Cash from financing | 1 | -1 | 1 | -2 | 9 | -6 |
| Net cash flow | 0 | -0 | 0 | -0 | 0 | 0 |
| Free cash flow | -0 | 0 | -1 | 2 | -8 | 6 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 126 | 34 | 48 | 45 | 80 | 65 |
| Inventory days | 77 | 168 | 121 | 147 | 128 | 110 |
| Days payable | 153 | 219 | 146 | 123 | 99 | 115 |
| Cash conversion cycle | 50 | -16 | 23 | 70 | 109 | 60 |
| Working capital days | 11 | -107 | -33 | 15 | -28 | -64 |
| Return on capital employed | −5.3% | −24.0% | 7.6% | 10.2% | −22.7% | −1.3% |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Ownership
Who owns it
Promoters hold 71.73% as of Jun 2026.
- Promoters 71.73%
- Public 28.27%
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- +13.63 pp 21.46% held
The same filing shows 4 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Vadivarhe Speciality Chemicals Ltd above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| 40.25% | −6.99 pp | |
| 21.46% | +13.63 pp | |
| 10.00% | −1.73 pp | |
| 1.48% | −0.26 pp | |
| 1.26% | −0.22 pp | |
| 0.02% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for Vadivarhe Speciality Chemicals Ltd
Free account: one company. Everything above stays public.
Write why you follow Vadivarhe Speciality Chemicals Ltd and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Chemicals companies
- SH
SHIVAAGROShiva Global Agro Industries Limited - SN
SNEHAASnehaa Organics Limited - SE
SEYAINDSeya Industries Limited - PR
PROLIFEProlife Industries Ltd - BO
BOHRAINDBohra Industries Limited - NO
NOLNational Oxygen Ltd. - AR
ARUNAYAArunaya Organics Ltd - TE
TECILCHEMTECIL Chemicals and Hydro Power Limited
Learn to analyse Vadivarhe Speciality Chemicals Ltd
Guides on how to read this kind of business and the numbers that matter.